查詢結果分析
相關文獻
- 個別衛教對慢性腎衰竭患者疾病認知、態度、自我照顧之成效
- 衛生教育對於榮民之家高血壓老人自我照顧行為與血壓控制之影響
- 促進血液透析患者自我照顧行為之衛生教育
- 慢性腎衰竭患者的疾病認知、態度及自我照顧行為之研究
- 老年糖尿病患經衛教後認知、態度及自我照顧行為的影響
- 糖尿病人足部傷口照護不同衛教模式之比較
- Predictors of Dysmenorrhea and Self-Care Behavior among Vocational Nursing School Female Students
- 登革熱病媒蚊之孳生源清除及防治宣導
- 臺中、彰化、雲林地區登革熱病媒蚊孳生源清除及宣導計畫報告
- 二十一世紀我國衛生教育之展望
頁籤選單縮合
題 名 | 個別衛教對慢性腎衰竭患者疾病認知、態度、自我照顧之成效=Effectiveness of Individualized Health Education on Knowledge, Attitude and Self-Care Behavior of Patients with Chronic Renal Failure |
---|---|
作 者 | 吳佩蓉; 許淑蓮; 蔡敦仁; 黃秀梨; | 書刊名 | 臺灣醫學 |
卷 期 | 1:1 1997.01[民86.01] |
頁 次 | 頁23-34 |
分類號 | 419.73 |
關鍵詞 | 衛生教育; 慢性腎衰竭; 自我照顧行為; Health education; Chronic renal failure; Self-care behavior; |
語 文 | 中文(Chinese) |
中文摘要 | 慢性腎衰竭威脅國人健康甚鉅,患者的疾病認知、態度及自我照顧行為,對於疾 病控制相當重要。研究顯示衛教對某些疾病患者的知識、態度或自我照顧行為正向的成效, 國外慢性腎衰竭衛教計劃之評價性研究甚少,且多以知識改變為評價指標,國內無此方面的 文獻報告,本研究針對慢性腎衰竭病人的需求設計衛教方案,探討個別性衛生教育對慢性腎 衰竭病人疾病認知、態度及自我照顧行為的成效及影響因素。研究採準實驗設計,收取 68 位 個案為研究對象,包括對照組 35 位、實驗組 33 位,平均年齡 57.4 歲,男性 43 位,女 性 25 位,結果發現個別性衛生教育能增進慢性腎衰竭病人的疾病認知及自我照顧行為,對 疾病及自我照顧的態度也愈趨正向。研究中慢性腎衰竭患者的疾病認知改變量受個別性衛教 、教育程度、症狀經驗數、參與慢性腎衰竭課程、疾病認知及態度前測成績等變項影響;疾 病態度改變量則受個別性衛教、知道自己血清肌酸酐值、 血清肌酸酐值及疾病態度前測 成績等變項的影響;自我照顧行為改變量受個別性衛教及自我照顧行為前測成績的影響。本 研究結果可供臨床醫療人員照護慢性腎衰竭患者及發展相關衛教計畫之參考。 |
英文摘要 | Neurtropenia is a blood disease. Severe neutropenia is most often drug- induced. Though the incidence is low, it can be fatal. Therefore, the use of neutropenia-inducing drugs needs to be closely monitored. Proper care and treatment is essential should neutropenia occur. We report a 70-years-old female patient with agranulocytosis induced by the antiplatelet agent, ticlopidine in National Cheng Kung University Hospital. This patient, who had unstable angina, was hospitalized for recurrent chest pain. During hospitalization, aspirin was initially used to treat coronary artery disease, and was later changed to ticlopidine because of suspicious gastrointestinal bleeding symptom. After 38 days of treatment, the patient's white blood cell count (WBC) lowered to 2.1 X 10 �e /L, with absolute neutrophil count(ANC) 0.168X 10 �e /L, hemoglobin 9.g/dl and platelet count 217 X 10 �e /L. The patient suffered from complicated infection and fever, which was suspected to be caused by ticlopidine-induced agranulocytosis. Ticlopidine was immediately discontinued and granulocyte colony stimulating factor and antibiotics were given. One week later, the patient's WBC increased to 15.4 X 10 �e /L, ANC to 8.9 X 10 �e /L, and the patient's condition improved. This article focuses on the mechanism and management of neutropenia induced by the antiplatelet agent, ticlopidine. Relevant reports and articles are also reviewed. We hope that through this case discussion, both physicians and pharmacists will become alert to the clinical indications and safety of ticlopidine, as well as to the importance of drug monitoring. We also address how clinical pharmacists can help in detecting drug-induced agranulocytosis and provide appropriate suggestions when necessary. |
本系統中英文摘要資訊取自各篇刊載內容。